-
Transient crispr-cas treatment can prevent reactivation of hiv-1 replication in a latently infected t-cell line
Liu, Y., Jeeninga, R. E., Klaver, B., Berkhout, B. & Das, A. T., 1 Dec 2021, In: Viruses. 13, 12, 2461.Research output: Contribution to journal › Article › Academic › peer-review
- All publications